Suggestions
Feras Al Tarifi
Strategic Business Development Director & Central Tender Business Director at TQ Pharma
Professional Background
Feras Tarifi is a dynamic and multi-talented professional who has made a significant impact in the pharmaceutical industry through his extensive expertise and adaptable nature. With a robust career spanning several key roles, Feras has demonstrated exceptional skills in strategic business development, marketing, governmental affairs, and business intelligence. Currently serving as the Strategic Business Development Director and Central Tender Business Director at TQ Pharma, he is focused on driving business growth and fostering collaboration across departments to achieve success. His career reflects a commitment to excellence and a keen understanding of market dynamics.
Before his current role, Feras honed his skills at Hikma Pharmaceuticals, where he held several pivotal positions, including Pharma Industry Professional and Government Affairs Manager. His dedication to navigating the complexities of the pharmaceutical sector positioned him as a leader in managing tenders and governmental relationships across the MENA region. His extensive experience also includes being the Business Intelligence Unit Manager at Hikma Pharmaceuticals, where he was instrumental in leveraging data to inform strategic decisions and maximize business outcomes.
Feras's journey in the pharmaceutical landscape began with a strong foundation in marketing, where he served as both a Marketing Manager at Abbott and Solvay Pharmaceuticals, overseeing marketing initiatives in diverse markets including Jordan, Iraq, Palestine, and Syria. His multifaceted skill set—emphasizing innovation, initiation, and building credibility—sets him apart in an industry that constantly evolves.
Education and Achievements
Feras Tarifi's educational background is equally impressive, holding a Bachelor's degree in Pharmacy from the University of Jordan, where he graduated with a commendable GPA of 3.55 out of 4. Further enriching his educational journey, he underwent specialized pharmacy training at Creighton University, equipping him with valuable insights into pharmaceutical best practices and innovative health solutions.
His academic credentials, combined with hands-on experience in the pharmaceutical sector, have enabled Feras to develop a strategic mindset that complements his operational capabilities. His vision is anchored in achieving cumulative results both as an individual and as part of a collaborative team effort, emphasizing the belief that innovation and initiation are key drivers for business success.
Key Achievements
Feras Tarifi’s career is marked by numerous achievements that highlight his commitment to excellence in the pharmaceutical industry. His strategic initiatives at TQ Pharma have played a crucial role in advancing the company's objectives, showcasing his ability to harness opportunities and deliver measurable business results. His success in managing tenders and governmental affairs at Hikma Pharmaceuticals has positioned him as a trusted leader in the MENA region, enhancing relationships across various stakeholders and entities.
Known for his networking prowess, Feras has established credible connections that foster a collaborative environment conducive to achieving mutually beneficial outcomes. His ability to navigate cross-functional teams and departments has not only contributed to his personal career growth but also the overall success of the organizations he has been a part of. Feras is well-regarded for his philosophy that “actions speak louder than interviews,” a testament to his belief in tangible results and continuous improvement.
Feras Tarifi embodies the spirit of a modern business leader—one who is committed to leaving a noticeable fingerprint on business results development while also advocating for innovation and teamwork. His track record speaks volumes about his professional journey, reflecting a blend of education, experience, and a deep understanding of the pharmaceutical industry’s complexities.
